LANHAM O'DELL & COMPANY, INC. Catalyst Pharmaceuticals, Inc. Transaction History

LANHAM O'DELL & COMPANY, INC. portfolio value:

$258,000
portfolio value

Catalyst Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 20.14K shares 258K $12.83 20.14K
Q2 2022 share Decrease -100.00% -26.5K shares -220K $7.01 0
Q1 2022 share Decrease -47.00% -23.5K shares -119K $8.29 26.5K
Q4 2021 share Increase 0.00% 50K shares 339K $6.89 50K